iANTHUS CAPITAL HOLDINGS (ITHUF) Cash from Financing Activities (2020 - 2026)

iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Cash from Financing Activities came in at -$62000.0 in Q1 2026, up 99.25% year-on-year from -$31116.7 in Q1 2025, and up 86.43% quarter-over-quarter from -$457000.0 in Q4 2025.

iANTHUS CAPITAL HOLDINGS (ITHUF) Cash from Financing Activities (2020 - 2026) Analysis & Trends

iANTHUS CAPITAL HOLDINGS has disclosed Cash from Financing Activities across 7 years of filings, most recently posting -$62000.0 for Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at -$62000.0, up 99.25% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.5 million (up 47.68% YoY), and the FY2025 annual result was -$12.7 million, down 3638.05% from the prior year.
  • Cash from Financing Activities came in at -$62000.0 for Q1 2026 at iANTHUS CAPITAL HOLDINGS, up from -$457000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $24.2 million in Q2 2022 to a low of -$8.3 million in Q1 2025.
  • The 5-year median for Cash from Financing Activities is -$160000.0 (2024), against an average of $492529.4.
  • Across the five-year window, Cash from Financing Activities surged 173200.0% in 2022 and plunged 13673.33% in 2025, its largest moves.
  • iANTHUS CAPITAL HOLDINGS's Cash from Financing Activities stood at -$1.8 million in 2022, then jumped by 82.38% to -$324000.0 in 2023, then soared by 50.62% to -$160000.0 in 2024, then slumped by 185.62% to -$457000.0 in 2025, then surged by 86.43% to -$62000.0 in 2026.
  • The last three Cash from Financing Activities figures came in at -$62000.0 (Q1 2026), -$457000.0 (Q4 2025), and -$3.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 iANTHUS CAPITAL HOLDINGS - - 15.92 Mn -62,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -62,000.00
Mar 31, 2026 -62,000.00
Dec 31, 2025 -457,000.00
Dec 31, 2025 -457,000.00
Sep 30, 2025 -2.96 Mn
Sep 30, 2025 -2.96 Mn
Jun 30, 2025 -991,000.00
Jun 30, 2025 -991,000.00
Mar 31, 2025 -8.26 Mn
Mar 31, 2025 -8.26 Mn
Dec 31, 2024 -160,000.00
Dec 31, 2024 -160,000.00
Sep 30, 2024 -104,000.00
Sep 30, 2024 -104,000.00
Jun 30, 2024 -15,000.00
Jun 30, 2024 -15,000.00
Mar 31, 2024 -60,000.00
Mar 31, 2024 -60,000.00
Dec 31, 2023 -324,000.00
Dec 31, 2023 -324,000.00